Oncorus' Series A - II Round

Oncorus raised a round of funding on July 19, 2016.

Oncorus is a pre-clinical stage biotechnology company developing oncolytic HSV products with the potential to recruit all arms of immune system to treat solid tumors.…

Articles about Oncorus' Series A - II Round: